Point72 Asset Management
ASMB icon

Point72 Asset Management’s Assembly Biosciences ASMB Stock Holding History

Point72 Asset Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.7M Buy
460,593
+116,488
+34% +$3.17M 0.01% 1138
2026
Q1 		$9.55M Sell
344,105
-256,504
-43% -$7.32M 0.01% 1288
2025
Q4 		$20.4M Buy
600,609
+304,592
+103% +$9.81M 0.02% 873
2025
Q3 		$7.58M Buy
+296,017
New +$6.49M 0.01% 910
2019
Q2 		– Sell
-8,333
Closed -$1.97M – 1328
2019
Q1 		$1.97M Buy
+8,333
New +$2.11M 0.01% 702
2018
Q4 		– Sell
-913
Closed -$407K – 956
2018
Q3 		$407K Buy
+913
New +$428K ﹤0.01% 939

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SFCM
Seven Fleet Capital Management Mountain View, California $606M AUM

Point72 Asset Management's ASMB Position: Q2 2026 in Review

Point72 Asset Management increased its Assembly Biosciences (ASMB) stake by 34% in Q2 2026, buying an estimated $3.17M and bringing the position to 460,593 shares worth $12.7M. The position accounts for 0.01% of the portfolio, ranked #1138.

Point72 Asset Management first reported a position in ASMB in Q3 2018 and has held it in 6 quarters since. The position peaked at $20.4M in Q4 2025. 93 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

  • Point72 Asset Management held 460,593 shares of Assembly Biosciences worth $12.7M as of Q2 2026.
  • Point72 Asset Management bought 116,488 Assembly Biosciences shares in Q2 2026, an estimated $3.17M.
  • Assembly Biosciences made up 0.01% of Point72 Asset Management's portfolio in Q2 2026, its #1138 holding.
  • Point72 Asset Management first reported a position in Assembly Biosciences in Q3 2018 and has held it in 6 quarters since.
  • Point72 Asset Management's Assembly Biosciences position peaked at $20.4M in Q4 2025.
  • 93 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.